Nanostructure-based surface-enhanced Raman scattering for diagnosis of cancer.

Area of Science:

• Biomedical Optics
• Nanotechnology
• Molecular Diagnostics

Background:

• Cancer poses a significant global health challenge, necessitating advanced diagnostic tools.
• Early cancer detection and treatment are crucial for improving patient survival rates.
• Surface-enhanced Raman scattering (SERS) is a powerful technique for sensitive, high-specificity molecular detection.

Purpose of the Study:

• To review the latest advancements in SERS technology for cancer diagnosis.
• To highlight nanotechnological approaches utilizing SERS for detecting cancer biomarkers.
• To explore the future potential of nanostructure-based SERS in oncology.

Main Methods:

• Review of current scientific literature on SERS applications in cancer diagnosis.
• Focus on nanotechnological strategies for SERS substrate development.
• Analysis of SERS performance metrics including sensitivity, specificity, and reproducibility.

Main Results:

• SERS enables single-molecule level detection, crucial for identifying cancer biomarkers.
• The performance of SERS is critically dependent on substrate properties (size, morphology, reproducibility).
• Nanostructured SERS substrates demonstrate significant potential for enhanced cancer detection.

Conclusions:

• SERS, particularly with nanostructured substrates, is a promising technology for early cancer diagnosis.
• Reproducible and chemically stable SERS substrates are key for clinical translation.
• Further development of nanotechnological SERS approaches will advance cancer biomarker detection and patient outcomes.